+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cystic Fibrosis Therapeutics Market

  • PDF Icon

    Report

  • 200 Pages
  • May 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 5968440
The global cystic fibrosis therapeutics market accounted for USD 12.53 billion in 2023 and is expected to reach USD 146.13 billion by 2034 with a CAGR of 25.02% during the forecast period 2024-2034. The market will grow as a result of the rising incidence of cystic fibrosis, improvements in treatment options, government support and initiatives, a growing pipeline of therapeutic candidates, and strategic alliances and collaborations.

A key factor propelling the market is the increased incidence of cystic fibrosis in the globe. The need for therapeutic interventions has been driven by the discovery of more instances as a result of improved diagnostic methods and raised awareness. Research and development in the field of cystic fibrosis have been actively promoted by numerous governments and healthcare organizations worldwide. This involves providing financial support for patient assistance programs, regulatory clearances, and clinical trials, all of which promote market expansion. For instance, in October 2023, the US FDA expanded Trikafta's license to include youngsters as young as 2 years old who have at least one copy of the F508del mutation in their treatment of cystic fibrosis.

By drug class, the cystic fibrosis transmembrane conductance regulator (CFTR) modulators segment accounted for the highest revenue-grossing segment in the global cystic fibrosis therapeutics market in 2023 and is estimated to grow at the fastest CAGR during the forecast period owing to the rapid pace of research and development, continuous improvements in drug formulations, and increasing adoption of precision medicine approaches tailored to individual patients' genetic profiles. For instance, AbbVie and The Bill & Melinda Gates Foundation announced in February 2024 that they would be working together to develop and market novel therapies for genetic disorders, such as cystic fibrosis, in low- and middle-income nations.

By route of administration, the oral segment accounted for the highest revenue-grossing segment in the global cystic fibrosis therapeutics market in 2023 and is estimated to grow at the fastest CAGR during the forecast period owing to the convenience and ease of administration, improved patient compliance, advancements in drug delivery technologies facilitating better bioavailability, and a shift towards oral formulations as preferred treatment options. For instance, Vertex announced encouraging outcomes in April 2024 from a Phase 2 proof-of-concept clinical trial assessing VX-561, a potential next-generation corrector, in individuals with cystic fibrosis.

By distribution channel, the hospital pharmacies segment accounted for the highest revenue-grossing segment in the global cystic fibrosis therapeutics market in 2023 owing to the increased prevalence of cystic fibrosis-related complications requiring specialized care and treatment within hospital settings, alongside the availability of a wide range of therapeutic options and comprehensive medical support services. For instance, Genentech said in October 2023 that the FDA had approved a new indication for their cystic fibrosis medication, allowing young patients ages 6 to 11 to use it. Additionally, the online pharmacies segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing adoption of digital health solutions, rising preference for convenient and discreet medication procurement, expanding internet penetration, and the growing trend towards telemedicine and remote healthcare services.

North American region is anticipated to have the highest revenue share during the forecast period owing to the well-established healthcare infrastructure, high prevalence of cystic fibrosis cases, early adoption of advanced therapeutic options, and strong presence of key market players and research institutions specializing in cystic fibrosis treatment. Additionally, the Asia Pacific region is estimated to grow at the fastest CAGR during the forecast period owing to the rapidly expanding healthcare infrastructure, rising awareness about cystic fibrosis, increasing healthcare expenditure, and growing initiatives by governments and healthcare organizations to improve access to advanced therapeutics. For instance, Novartis published encouraging initial results in February 2024 from a Phase 3 clinical trial assessing its CFTR modulator treatment in patients with cystic fibrosis.

This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.

Report Scope:

  • Base Year: 2023
  • Forecast Period: 2024-2034
  • Study Coverage
  • Market Forecast by Drug Class, Route of Administration, and Distribution Channel
  • Market Forecast for 5 Regions and 17+ Countries
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
  • Exhaustive Company Profiles of the Top 10+ Major Market Players

Segmentation: Cystic Fibrosis Therapeutics Market Report 2023 - 2034

Cystic Fibrosis Therapeutics Market Analysis & Forecast by Drug Class 2023 - 2034 (Revenue USD Bn)

  • Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
  • Bronchodilators
  • Mucolytic
  • Pancreatic Enzyme Supplement
  • Others

Cystic Fibrosis Therapeutics Market Analysis & Forecast by Route of Administration 2023 - 2034 (Revenue USD Bn)

  • Oral
  • Parenteral
  • Others

Cystic Fibrosis Therapeutics Market Analysis & Forecast by Distribution Channel 2023 - 2034 (Revenue USD Bn)

  • Retail Pharmacies and Drug Stores
  • Online Pharmacies
  • Hospital Pharmacies

Cystic Fibrosis Therapeutics Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Cystic Fibrosis Therapeutics Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Cystic Fibrosis Therapeutics Market: Drug Class Estimates & Trend Analysis
7.1. Drug Class Segment Opportunity Analysis
7.2. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
7.2.1. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Bronchodilators
7.3.1. Bronchodilators Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. Mucolytic
7.4.1. Mucolytic Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.5. Pancreatic Enzyme Supplement
7.5.1. Pancreatic Enzyme Supplement Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.6. Others
7.6.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Cystic Fibrosis Therapeutics Market: Route of Administration Estimates & Trend Analysis
8.1. Route of Administration Segment Opportunity Analysis
8.2. Oral
8.2.1. Oral Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Parenteral
8.3.1. Parenteral Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Others
8.4.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Cystic Fibrosis Therapeutics Market: Distribution Channel Estimates & Trend Analysis
9.1. Distribution Channel Segment Opportunity Analysis
9.2. Retail Pharmacies and Drug Stores
9.2.1. Retail Pharmacies and Drug Stores Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Online Pharmacies
9.3.1. Online Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Hospital Pharmacies
9.4.1. Hospital Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4.2. institutes Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Regional Market Analysis
10.1. Regional Market Opportunity Analysis
11. North America Cystic Fibrosis Therapeutics Market
11.1. North America Cystic Fibrosis Therapeutics Market
11.1.1. North America Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. North America Cystic Fibrosis Therapeutics Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. North America Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
11.1.4. North America Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
11.1.5. North America Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.2. U.S. Global Cystic Fibrosis Therapeutics Market
11.2.1. U.S. Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. U.S. Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
11.2.3. U.S. Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
11.2.4. U.S. Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.3. Canada Global Cystic Fibrosis Therapeutics Market
11.3.1. Canada Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. Canada Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
11.3.3. Canada Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
11.3.4. Canada Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12. Europe Global Cystic Fibrosis Therapeutics Market
12.1. Europe Global Cystic Fibrosis Therapeutics Market
12.1.1. Europe Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Europe Cystic Fibrosis Therapeutics Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Europe Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.1.4. Europe Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
12.1.5. Europe Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.2. Germany Global Cystic Fibrosis Therapeutics Market
12.2.1. Germany Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Germany Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.2.3. Germany Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
12.2.4. Germany Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.3. UK Global Cystic Fibrosis Therapeutics Market
12.3.1. UK Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. UK Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.3.3. UK Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
12.3.4. UK Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.4. France Global Cystic Fibrosis Therapeutics Market
12.4.1. France Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. France Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.4.3. France Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
12.4.4. France Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.5. Spain Global Cystic Fibrosis Therapeutics Market
12.5.1. Spain Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. Spain Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.5.3. Spain Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
12.5.4. Spain Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.6. Italy Global Cystic Fibrosis Therapeutics Market
12.6.1. Italy Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Italy Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.6.3. Italy Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
12.6.4. Italy Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.7. Rest of Europe Global Cystic Fibrosis Therapeutics Market
12.7.1. Rest of Europe Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Europe Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Europe Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
12.7.4. Rest of Europe Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13. Asia Pacific Global Cystic Fibrosis Therapeutics Market
13.1. Asia Pacific Global Cystic Fibrosis Therapeutics Market
13.1.1. Asia Pacific Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Asia Pacific Cystic Fibrosis Therapeutics Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Asia Pacific Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.1.4. Asia Pacific Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.1.5. Asia Pacific Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.2. Japan Global Cystic Fibrosis Therapeutics Market
13.2.1. Japan Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Japan Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.2.3. Japan Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.2.4. Japan Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.3. China Global Cystic Fibrosis Therapeutics Market
13.3.1. China Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. China Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.3.3. China Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.3.4. China Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.4. India Global Cystic Fibrosis Therapeutics Market
13.4.1. India Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. India Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.4.3. India Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.4.4. India Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.5. South Korea Global Cystic Fibrosis Therapeutics Market
13.5.1. South Korea Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. South Korea Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.5.3. South Korea Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.5.4. South Korea Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.6. Australia Global Cystic Fibrosis Therapeutics Market
13.6.1. Australia Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Australia Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.6.3. Australia Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.6.4. Australia Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.7. Rest of Asia Pacific Global Cystic Fibrosis Therapeutics Market
13.7.1. Rest of Asia Pacific Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Asia Pacific Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Asia Pacific Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Asia Pacific Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14. Latin America Global Cystic Fibrosis Therapeutics Market
14.1. Latin America Global Cystic Fibrosis Therapeutics Market
14.1.1. Latin America Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Latin America Cystic Fibrosis Therapeutics Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Latin America Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.1.4. Latin America Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.1.5. Latin America Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.2. Brazil Global Cystic Fibrosis Therapeutics Market
14.2.1. Brazil Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Brazil Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.2.3. Brazil Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.2.4. Brazil Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.3. Mexico Global Cystic Fibrosis Therapeutics Market
14.3.1. Mexico Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. Mexico Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.3.3. Mexico Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.3.4. Mexico Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.4. Argentina Global Cystic Fibrosis Therapeutics Market
14.4.1. Argentina Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Argentina Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.4.3. Argentina Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.4.4. Argentina Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.5. Rest of Latin America Global Cystic Fibrosis Therapeutics Market
14.5.1. Rest of Latin America Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. Rest of Latin America Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.5.3. Rest of Latin America Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
14.5.4. Rest of Latin America Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15. MEA Global Cystic Fibrosis Therapeutics Market
15.1. MEA Global Cystic Fibrosis Therapeutics Market
15.1.1. MEA Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. MEA Cystic Fibrosis Therapeutics Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. MEA Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.1.4. MEA Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.1.5. MEA Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.2. GCC Global Cystic Fibrosis Therapeutics Market
15.2.1. GCC Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. GCC Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.2.3. GCC Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.2.4. GCC Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.3. South Africa Global Cystic Fibrosis Therapeutics Market
15.3.1. South Africa Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. South Africa Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.3.3. South Africa Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.3.4. South Africa Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.4. Rest of MEA Global Cystic Fibrosis Therapeutics Market
15.4.1. Rest of MEA Cystic Fibrosis Therapeutics Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Rest of MEA Cystic Fibrosis Therapeutics Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.4.3. Rest of MEA Cystic Fibrosis Therapeutics Market Size and Forecast, By Route of Administration, 2023-2034 (Revenue USD Bn)
15.4.4. Rest of MEA Cystic Fibrosis Therapeutics Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16. Competitor Analysis
16.1. Company Market Share Analysis, 2023
16.2. Major Recent Developments
17. Company Profiles
17.1. Vertex Pharmaceuticals Incorporated
17.2. AbbVie Inc.
17.3. Genentech (Roche)
17.4. Gilead Sciences, Inc.
17.5. Novartis AG
17.6. Chiesi Farmaceutici S.p.A.
17.7. Merck & Co., Inc.
17.8. Boehringer Ingelheim International GmbH
17.9. Mylan N.V.
17.10. Proteostasis Therapeutics, Inc.
17.11. Galapagos NV
17.12. Celtaxsys, Inc.
17.13. Translate Bio, Inc.
17.14. Zambon S.p.A.
17.15. PTC Therapeutics, Inc.
18. Conclusion19. Recommendations

Companies Mentioned

  • Vertex Pharmaceuticals Incorporated
  • AbbVie Inc.
  • Genentech (Roche)
  • Gilead Sciences Inc.
  • Novartis AG
  • Chiesi Farmaceutici S.p.A.
  • Merck & Co. Inc.
  • Boehringer Ingelheim International GmbH
  • Mylan N.V.
  • Proteostasis Therapeutics Inc.
  • Galapagos NV
  • Celtaxsys Inc.
  • Translate Bio Inc.
  • Zambon S.p.A.
  • PTC Therapeutics Inc.